Immunocore Holdings plc (IMCR)
NASDAQ: IMCR · Real-Time Price · USD
30.53
-0.11 (-0.36%)
Sep 29, 2026, 9:56 AM EDT - Market open
Immunocore Holdings Market Cap
Immunocore Holdings has a market cap or net worth of $1.57 billion as of September 29, 2026. Its market cap has decreased by -8.28% in one year.
Market Cap
1.57B
Enterprise Value
1.13B
1-Year Change
-8.28%
Ranking
Category
Stock Price
$30.53
ChartMarket Cap Chart
Since February 5, 2021, Immunocore Holdings's market cap has decreased from $1.80B to $1.57B, a decrease of -12.46%. That is a compound annual growth rate of -2.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 29, 2026 | 1.57B | -10.36% |
| Dec 31, 2025 | 1.75B | 18.83% |
| Dec 31, 2024 | 1.48B | -56.30% |
| Dec 29, 2023 | 3.38B | 23.54% |
| Dec 30, 2022 | 2.73B | 82.12% |
| Dec 31, 2021 | 1.50B | -16.41% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Absci | 1.67B |
| Intellia Therapeutics | 1.65B |
| GH Research | 1.64B |
| Rapport Therapeutics | 1.63B |
| Syndax Pharmaceuticals | 1.63B |
| Hemab Therapeutics Holdings | 1.62B |
| Stoke Therapeutics | 1.60B |
| AnaptysBio | 1.52B |